PEDIATRICS Vol. 62 No. 6 December 1978, pp. 1098-1103
This Article
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rooks, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rooks, J. B.

Estrogen Treatment of Teenage Girls in the United States: Description of the Treated Population

Judith Bourne Rooks C.N.M., M.S., M.P.H.1

1 Epidemiologic Studies Branch, Family Planning Evaluation Division, Bureau of Epidemiology, Center for Disease Control, Atlanta

It is estimated that each year approximately 20% of all 15- to 19-year-old American girls receive estrogens in the form of a pharmaceutical agent. The proportion of blacks in this age group who receive some form of estrogen therapy is estimated at 36%. The great majority of estrogen use is for the purposes of contraception and, to a lesser extent, suppression of lactation following childbirth. Less than 1% of the girls in this age group receive estrogen for treatment of medical conditions.